GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. - Wikidata - awgldk - TriplyDB

GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice.

GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice.

http://www.wikidata.org/entity/Q41611744

about

A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease Innate immunity in Alzheimer's disease: a complex affair Checkpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous System The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions.Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice.Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 mice Human umbilical cord plasma proteins revitalize hippocampal function in aged mice.pH responsive granulocyte colony-stimulating factor variants with implications for treating Alzheimer's disease and other central nervous system disorders.The immunology of neurodegeneration.Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients.Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.Young microglia restore amyloid plaque clearance of aged microglia.Granulocyte colony-stimulating factor promotes behavioral recovery in a mouse model of traumatic brain injury.Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study.Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology.Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research.Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review.Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.Hematopoietic cytokines as therapeutic players in early stages Parkinson's disease.Effects of an Inhibitor of Monocyte Recruitment on Recovery from Traumatic Brain Injury in Mice Treated with Granulocyte Colony-Stimulating Factor.Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APP(Swe)/PS1 mice.Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade.Insights into the protective role of immunity in neurodegenerative disease.Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by granulocyte-/granulocyte-macrophage colony stimulating factors.Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease.Exosomal biomarkers in Down syndrome and Alzheimer's disease.Granulocyte-colony stimulating factor promotes brain repair following traumatic brain injury by recruitment of microglia and increasing neurotrophic factor expression.Transient Microneedle Insertion into Hippocampus Triggers Neurogenesis and Decreases Amyloid Burden in a Mouse Model of Alzheimer's Disease.Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review

P2860

Q26997058-2F5019AF-F078-4703-9AE6-C4CAFB98D77A Q27006944-7FD5D3F2-1060-44A7-9C0F-4EDB412EAB1F Q28066906-804E7BD7-B3DD-45B4-BF9F-DB80547104FA Q30463376-1CA5CD3A-1C0E-4E41-9C33-B3AE729258EF Q33576437-B3807A43-10D8-45FB-8606-CB7371AD57C4 Q34059086-4C1E0411-AE56-4473-A713-9FAF7C8851E9 Q34222718-699C0CC9-E5EB-4FD4-A0D4-1300230D9009 Q34391616-878FF1CB-CC18-4764-9C0F-B6F21118FAF3 Q34429308-0F199C61-70FE-42F3-8747-711901A873EE Q34506405-D43CDDF7-F7DE-4CAD-929C-985687187E16 Q34555450-585E3CFF-8198-437D-ADCA-78DA8F8F816B Q35602819-BB7380A4-AD9E-42ED-A92E-27644A18E335 Q35860997-0DADA152-F726-4C00-93A4-2EC412685D1E Q36173185-77AF9571-F4CD-4C88-AE59-369E0D99F988 Q36229543-C8D3265D-EFF3-41AB-A911-A498E3D26DD5 Q36231976-DFD1EE1B-5FD3-4C59-BC6E-B0A45EC2B4EC Q36723127-757064A5-F85E-4E4A-98A2-C9F86C7A5DE6 Q37043925-B7D43FBD-FB91-4249-BB1B-227413E3C082 Q37199042-BDEAD3A7-A6A3-453A-879D-670EA0EC6556 Q37413434-46F1CC03-C570-42BA-B593-2742CE4717C7 Q38021993-60F10CA8-4D1F-4BFB-ABAD-94CCFA5E24F6 Q38061480-A645F403-2368-4816-8B3A-EB47EBE2CDA0 Q38283308-FD5508EA-7841-47EC-BE36-B4C1DA82699E Q38388693-0DAFA72E-13E1-46D6-888E-F0C2E77CE023 Q39216779-92A56D13-4B4C-4597-9B20-93391449A484 Q39296351-4443E91A-EC5E-482B-AB49-C43323647906 Q40719044-04CEE8B1-AE70-46F4-850D-1A4919C7D84F Q41181881-DDFC64C1-2BD6-4E78-B8D8-5154192146B7 Q41596551-389CCCCE-7746-47F2-B78A-CEBF0D569EC2 Q41876717-AC5E35DA-EE7F-4A6A-8BD9-D12758D4BECF Q42247507-8F26075D-2776-4AC7-A859-6DE84177688B Q42320546-267640B2-A012-4659-B4D4-6232E18BAE2F Q42844654-8755D614-4045-4C01-BF78-CB8F043D05D7 Q43106647-048DC24E-6B24-4F66-B448-A4C2C1FBDDB6 Q47960190-98B909E9-F058-4658-BDA3-252E6D890D6C Q48873132-AD3E2B1F-66C6-4C71-99ED-A9509C739BFE Q48894227-90BA9B78-6A0E-42BB-8DC1-0634756C0227 Q57816569-A843603A-3394-41D0-B96D-5966A00F8BDB Q58697971-B3A3F3D3-7510-4DD2-AA4B-B895CAE7256B

P2860

GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice.

http://www.wikidata.org/entity/Q41611744

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

GM-CSF upregulated in rheumato ...... amyloidosis in Alzheimer mice.

@en

type

label

GM-CSF upregulated in rheumato ...... amyloidosis in Alzheimer mice.

@en

prefLabel

GM-CSF upregulated in rheumato ...... amyloidosis in Alzheimer mice.

@en

P1433

Q41611744-EF476BAB-FB09-4F38-A4EB-08824352A099

P1476

Q41611744-CD5347A3-09D8-41B7-B931-17DC56B21EB9

P2093

Q41611744-03D5BAF0-110E-43A5-BB54-CF89F414B49B

Q41611744-4646B22F-AE54-40F6-AA63-2FDC954B0DEA

Q41611744-728D9089-2CF7-4740-83B4-34EA7D21DF60

Q41611744-7C1E6FDE-72B9-49FC-B6B3-0B6A391EDAE0

Q41611744-808411D6-9790-4743-BD4B-F49E3260EAD3

Q41611744-8244E559-FE22-4180-AD92-E5479523E92F

Q41611744-87F1901A-6F30-444E-A9F1-AA8A324917CE

Q41611744-89FBE61B-0CB3-410A-9630-D5F636F4AE3D

Q41611744-8D9DC7A2-7A96-4901-B026-66F05223350E

Q41611744-9EA426D5-40DE-45D2-8F29-600E62085467

P2860

Q41611744-07F096F1-0A9E-4740-B578-450D6C7F83C7

Q41611744-08593989-0474-463C-B2C4-B5282AE1B31F

Q41611744-0C8FDE2D-24C1-4FA8-AEFC-7B7E95DE3529

Q41611744-12988F25-BF1C-4FB3-B835-B8B3C487F9FB

Q41611744-15B8871D-ED83-4C00-8DAD-F5B2137850EC

Q41611744-1DB248AC-C4F9-490C-BA91-EE8FFC01449B

Q41611744-1E0710E1-D606-410F-BE0E-B1D4E8FBC89D

Q41611744-1FBB607B-F3A4-4FF8-AEEE-75897A5B5F7D

Q41611744-2066BCBA-3D6E-4CAE-AFF7-5036AC9783E4

Q41611744-21F17188-82BC-4E2C-B5F6-457BACD0BBA0

P304

Q41611744-A5B5626E-E345-4549-A16A-CD09A6AB286D

P31

Q41611744-4E6E436D-2A13-4D68-853D-820B4F284D25

P356

Q41611744-8053EBA2-C717-4D43-A39C-9F19C29B7D45

P433

Q41611744-C83B9700-355B-4EF9-B53A-573941FED28E

P478

Q41611744-C4181916-AF33-4E2C-A5CF-560B70CB87B2

P50

Q41611744-38F777C0-2D75-4214-8DE2-4B6C6EF09149

P577

Q41611744-63CEB4B2-63BD-4BEA-B1C7-9E1E457558EC

P5875

Q41611744-1DB8998F-9828-4903-BAE2-A0E6325308C0

P698

Q41611744-C6224029-C72E-46A4-8619-44E54B0447EE

P921

Q41611744-0598809D-9ABF-4660-AE93-0101A407B817

P932

Q41611744-D8B1FA2A-7FAB-4C86-BB34-2D285F77245D

P356

JAD-2010-091471

P1433

Journal of Alzheimer's Disease

P1476

GM-CSF upregulated in rheumato ...... amyloidosis in Alzheimer mice

@en

P2093

Gary W Arendash

http://www.w3.org/2001/XMLSchema#string

Huntington Potter

http://www.w3.org/2001/XMLSchema#string

Inge Wefes

http://www.w3.org/2001/XMLSchema#string

Jaya Padmanabhan

http://www.w3.org/2001/XMLSchema#string

Melissa Runfeldt

http://www.w3.org/2001/XMLSchema#string

Michelle Norden

http://www.w3.org/2001/XMLSchema#string

Nicholas Governatori

http://www.w3.org/2001/XMLSchema#string

Peter Neame

http://www.w3.org/2001/XMLSchema#string

Steven P Bennett

http://www.w3.org/2001/XMLSchema#string

Takashi Mori

http://www.w3.org/2001/XMLSchema#string

P2860

CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

Macrophages and their products in rheumatoid arthritis

Granulocyte-macrophage colony-stimulating factor-induced vessel growth restores cerebral blood supply after bilateral carotid artery occlusion.

The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro.

Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis

Erythropoietin: physiology and pharmacology update.

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.

Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.

P304

507-518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2010-091471

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Juan Sanchez-Ramos

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44679971

http://www.w3.org/2001/XMLSchema#string

P698

20555144

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5588158

http://www.w3.org/2001/XMLSchema#string